Why is Zenith Drugs falling/rising?

As of 14-Aug, Zenith Drugs Ltd is currently priced at 64.30, reflecting an increase of 1.0 or 1.58%. Despite this uptick, the stock has underperformed its sector by 2.17% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a decline of 2.58%, and its performance over the last month shows a significant drop of 14.27%. However, there has been a notable increase in investor participation, with delivery volume rising by 87.5% against the 5-day average, indicating some renewed interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the recent price movement.
Broader market context shows that while Zenith Drugs has experienced a decline of 20.42% year-to-date, the benchmark Sensex has gained 4.17% during the same period. This stark contrast highlights the stock's struggle relative to the broader market. In the short term, the stock's performance has been weaker than the benchmark, as indicated by its 1-week return compared to the Sensex's slight gain of 0.14%. Overall, while there is a minor increase in price today, the underlying trends suggest ongoing challenges for Zenith Drugs in the current market environment.